Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.DE Filed Acc 0000899243-20-029702

Options or other derivatives

  • Director acquired 24,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Harwin Peter Evan · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-10-27 Grant or award : show line 1 in the form Director Stock Option (Right to Buy) +24,000 24,000 D
Loading xslF345X03/doc4.xml…